Research & Development

Text size
view with small font size
view with medium font size
view with large font size

Immunology Research

Our research goal at Kyowa Kirin Pharmaceutical Research (KKR) is to advance the discovery of novel therapeutics in the area of immune-mediated disorders through translational research and open innovation. Our activities include:

A scientist performing and experiment in a lab.
  • Discovery of innovative drug candidates based on our proprietary antibody technologies.
  • Identification and validation of drug targets and in vitro testing of drug candidates by using patient-derived clinical samples.
  • In vivo characterization of drug candidates by use of mouse and humanized-mouse models of immune-mediated disorders.
  • Extensive internal collaborations with Kyowa Hakko Kirin (KHK) research and development teams, as well as external collaboration with companies and academic institutions, including the La Jolla Institute for Immunology (LJI) and University of California, San Diego (UCSD).

Platform Technologies

At KKR, we apply several platform technologies to aid our discovery efforts. These include KHK's Fully Human Antibody Discovery Technology, as well as proprietary POTELLIGENT®, COMPLEGENT®, and AccretaMab® Enhanced Antibody Activity Technologies. For more information about our proprietary technologies, please visit the Kyowa Hakko Kirin Global Site.

To Page Top